Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer
2014
Authors:
Steelman, Linda S.Davis, Nicole M.
Sokolosky, Melissa
Abrams, Stephen L.
Martelli, Alberto M.
Nicoletti, Ferdinando
Fagone, Paolo
Mazzarino, Clorinda
Malponte, Graziella
Libra, Massimo
Cervello, Melchiorre
Montalto, Giuseppe
Maksimović-Ivanić, Danijela
Mijatović, Sanja
Umezawa, Kazuo
McCubrey, James A.